Compass Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,218
Closed -$394K 97
2025
Q3
$394K Sell
1,218
-50
-4% -$15.6K 0.09% 119
2025
Q2
$493K Hold
1,268
0.12% 106
2025
Q1
$552K Sell
1,268
-200
-14% -$80.3K 0.14% 102
2024
Q4
$542K Sell
1,468
-50
-3% -$20.9K 0.13% 108
2024
Q3
$789K Sell
1,518
-50
-3% -$26.7K 0.19% 88
2024
Q2
$850K Hold
1,568
0.21% 88
2024
Q1
$813K Hold
1,568
0.2% 94
2023
Q4
$739K Sell
1,568
-25
-2% -$11.6K 0.21% 94
2023
Q3
$694K Sell
1,593
-65
-4% -$29.5K 0.22% 101
2023
Q2
$737K Hold
1,658
0.22% 98
2023
Q1
$762K Hold
1,658
0.24% 100
2022
Q4
$851K Buy
+1,658
New +$842K 0.28% 91

Other funds holding ELV

Compass Wealth Management's ELV Position: Q4 2025 in Review

Compass Wealth Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,218 shares — an estimated $394K sold.

Compass Wealth Management first reported a position in ELV in Q4 2022 and held it in 12 quarters. The position peaked at $851K in Q4 2022. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Compass Wealth Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 1,218 Elevance Health shares in Q4 2025, an estimated $394K.
  • Compass Wealth Management first reported a position in Elevance Health in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Elevance Health position peaked at $851K in Q4 2022.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.